CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | Lassiter Wright III Director | Grant or award · Phantom Stock Units | +190 | 190 | ||
| 2024-11-29 | PREVOZNIK MICHAEL E SVP & General Counsel | Option exercise | +35,146 | $86.63 | $3.0M | 73,624 |
| 2024-11-29 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −3,009 | $162.26 | $488K | 70,615 |
| 2024-11-29 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −32,137 | $163.15 | $5.2M | 38,478 |
| 2024-11-29 | PREVOZNIK MICHAEL E SVP & General Counsel | Option exercise · Non-Qualifed Stock Option (right to buy) | −35,146 | $86.63 | $3.0M | 0 |
| 2024-11-27 | Doherty Catherine T. EVP, Regional Businesses | Option exercise | +33,103 | $103.57 | $3.4M | 101,515 |
| 2024-11-27 | Doherty Catherine T. EVP, Regional Businesses | Sale | −4,803 | $162.14 | $779K | 96,712 |
| 2024-11-27 | Doherty Catherine T. EVP, Regional Businesses | Sale | −28,300 | $163.13 | $4.6M | 68,412 |
| 2024-11-27 | Doherty Catherine T. EVP, Regional Businesses | Option exercise · Non-Qualifed Stock Option (right to buy) | −33,103 | $103.57 | $3.4M | 0 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Option exercise | +8,635 | $71.17 | $615K | 43,576 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Option exercise | +10,120 | $66.51 | $673K | 53,696 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Sale | −2,100 | $152.70 | $321K | 51,596 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Sale | −2,400 | $153.98 | $370K | 49,196 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Sale | −4,135 | $154.74 | $640K | 45,061 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Sale | −2,600 | $152.71 | $397K | 42,461 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Sale | −2,331 | $154.03 | $359K | 40,130 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Sale | −5,189 | $154.74 | $803K | 34,941 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Option exercise · Non-Qualifed Stock Option (right to buy) | −8,635 | $71.17 | $615K | 0 |
| 2024-11-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Option exercise · Non-Qualifed Stock Option (right to buy) | −10,120 | $66.51 | $673K | 0 |
| 2024-10-28 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Sale | −1,775 | $156.92 | $279K | 9,734 |
Page 17 of 21 · 409 trades